A phase I study to assess safety, pharmacokinetics, and pharmacodynamics of a vaginal insert containing tenofovir alafenamide and elvitegravir.

Vemlidy (tenofovir alafenamide) - Gilead

Vitekta (elvitegravir) - Japan Tobacco, Gilead

tenofovir alafenamide/elvitegravir vaginal insert (TAF/EVG vaginal insert) - CONRAD

http://www.ncbi.nlm.nih.gov/pubmed/37153145

May 8, 2023